TY - JOUR AU - Indolfi, C. AU - Rosa, S. AU - Colombo, A. PY - 2016 DA - 2016// TI - Bioresorbable vascular scaffolds - basic concepts and clinical outcome JO - Nat Rev Cardiol VL - 13 UR - https://doi.org/10.1038/nrcardio.2016.151 DO - 10.1038/nrcardio.2016.151 ID - Indolfi2016 ER - TY - JOUR AU - Gori, T. AU - Münzel, T. PY - 2017 DA - 2017// TI - First Evidence of Complete Resorption 4 Years After Bioresorbable Scaffold Implantation in the Setting of ST-Segment Elevation Myocardial Infarction JO - JACC Cardiovasc Interv. VL - 10 UR - https://doi.org/10.1016/j.jcin.2016.10.022 DO - 10.1016/j.jcin.2016.10.022 ID - Gori2017 ER - TY - JOUR AU - Ormiston, J. A. AU - Serruys, P. W. PY - 2009 DA - 2009// TI - Bioabsorbable coronary stents JO - Circ Cardiovasc Interv VL - 2 UR - https://doi.org/10.1161/CIRCINTERVENTIONS.109.859173 DO - 10.1161/CIRCINTERVENTIONS.109.859173 ID - Ormiston2009 ER - TY - JOUR AU - Ormiston, J. A. AU - Serruys, P. W. AU - Regar, E. AU - Dudek, D. AU - Thuesen, L. AU - Webster, M. W. PY - 2008 DA - 2008// TI - A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60415-8 DO - 10.1016/S0140-6736(08)60415-8 ID - Ormiston2008 ER - TY - JOUR AU - Serruys, P. W. AU - Onuma, Y. AU - Dudek, D. AU - Smits, P. C. AU - Koolen, J. AU - Chevalier, B. PY - 2011 DA - 2011// JO - J Am Coll Cardiol VL - 58 UR - https://doi.org/10.1016/j.jacc.2011.05.050 DO - 10.1016/j.jacc.2011.05.050 ID - Serruys2011 ER - TY - JOUR AU - Gori, T. AU - Schulz, E. AU - Hink, U. AU - Wenzel, P. AU - Post, F. AU - Jabs, A. PY - 2014 DA - 2014// TI - Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes JO - EuroIntervention. VL - 9 UR - https://doi.org/10.4244/EIJV9I9A176 DO - 10.4244/EIJV9I9A176 ID - Gori2014 ER - TY - JOUR AU - Indolfi, C. AU - Mongiardo, A. AU - Spaccarotella, C. AU - Caiazzo, G. AU - Torella, D. AU - Rosa, S. PY - 2014 DA - 2014// TI - Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation JO - Circ Cardiovasc Imaging VL - 7 UR - https://doi.org/10.1161/CIRCIMAGING.114.001727 DO - 10.1161/CIRCIMAGING.114.001727 ID - Indolfi2014 ER - TY - JOUR AU - Gori, T. AU - Jansen, T. AU - Weissner, M. AU - Foin, N. AU - Wenzel, P. AU - Schulz, E. PY - 2016 DA - 2016// TI - Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanisms JO - Eur Heart J VL - 37 UR - https://doi.org/10.1093/eurheartj/ehv581 DO - 10.1093/eurheartj/ehv581 ID - Gori2016 ER - TY - JOUR AU - Gori, T. AU - Schulz, E. AU - Hink, U. AU - Kress, M. AU - Weiers, N. AU - Weissner, M. PY - 2015 DA - 2015// TI - Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes JO - JACC Cardiovasc Interv. VL - 8 UR - https://doi.org/10.1016/j.jcin.2014.12.244 DO - 10.1016/j.jcin.2014.12.244 ID - Gori2015 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - BMJ VL - 339 UR - https://doi.org/10.1136/bmj.b2535 DO - 10.1136/bmj.b2535 ID - Moher2009 ER - TY - JOUR AU - Polimeni, A. AU - Rosa, S. AU - Sabatino, J. AU - Sorrentino, S. AU - Indolfi, C. PY - 2016 DA - 2016// TI - Impact of intracoronary adenosine administration during primary PCI: A meta-analysis JO - Int J Cardiol VL - 203 UR - https://doi.org/10.1016/j.ijcard.2015.11.086 DO - 10.1016/j.ijcard.2015.11.086 ID - Polimeni2016 ER - TY - JOUR AU - Polimeni, A. AU - Passafaro, F. AU - Rosa, S. AU - Sorrentino, S. AU - Torella, D. AU - Spaccarotella, C. PY - 2015 DA - 2015// TI - Clinical and Procedural Outcomes of 5-French versus 6-French Sheaths in Transradial Coronary Interventions JO - Medicine (Baltimore) VL - 94 UR - https://doi.org/10.1097/MD.0000000000002170 DO - 10.1097/MD.0000000000002170 ID - Polimeni2015 ER - TY - JOUR AU - Santarpia, G. AU - Rosa, S. AU - Polimeni, A. AU - Giampà, S. AU - Micieli, M. AU - Curcio, A. PY - 2015 DA - 2015// TI - Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0126512 DO - 10.1371/journal.pone.0126512 ID - Santarpia2015 ER - TY - JOUR AU - Rosa, S. AU - Torella, D. AU - Caiazzo, G. AU - Giampà, S. AU - Indolfi, C. PY - 2014 DA - 2014// TI - Left radial access for percutaneous coronary procedures: from neglected to performer? A meta-analysis of 14 studies including 7,603 procedures JO - Int J Cardiol VL - 171 UR - https://doi.org/10.1016/j.ijcard.2013.11.046 DO - 10.1016/j.ijcard.2013.11.046 ID - Rosa2014 ER - TY - STD TI - Gao R. ABSORB China: two-year clinical results in patients with coronary artery disease randomized to the ABSORB bioresorbable vascular scaffold versus metallic drug-eluting stents. Transcatheter Cardiovascular Therapeutics. 2016; https://www.tctmd.com/slide/absorb-china-two-year-clinical-outcomes-prospective-randomized-trial-everolimus-eluting. Accessed 30 Oct 2016 UR - https://www.tctmd.com/slide/absorb-china-two-year-clinical-outcomes-prospective-randomized-trial-everolimus-eluting ID - ref15 ER - TY - JOUR AU - Onuma, Y. AU - Sotomi, Y. AU - Shiomi, H. AU - Ozaki, Y. AU - Namiki, A. AU - Yasuda, S. PY - 2016 DA - 2016// TI - Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial JO - EuroIntervention VL - 12 UR - https://doi.org/10.4244/EIJY16M09_01 DO - 10.4244/EIJY16M09_01 ID - Onuma2016 ER - TY - JOUR AU - Chevalier, B. AU - Onuma, Y. AU - Boven, A. J. AU - Piek, J. J. AU - Sabaté, M. AU - Helqvist, S. PY - 2016 DA - 2016// TI - Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial JO - EuroIntervention. VL - 12 UR - https://doi.org/10.4244/EIJY16M08_01 DO - 10.4244/EIJY16M08_01 ID - Chevalier2016 ER - TY - STD TI - Wykrzykowska JJ, Kraak RP, Hofma SH, Van der Schaaf RJ, Arkenbout EK, Ijsselmuiden AJ, et al. Bioresorbable scaffolds versus metallic stents in routine PCI. N Engl J Med. doi:10.1056/NEJMoa1614954. ID - ref18 ER - TY - STD TI - Ellis GS. Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results. Am Coll Cardiol. 2017; https://www.tctmd.com/slide/everolimus-eluting-bioresorbable-vascular-scaffolds-patients-coronary-artery-disease-absorb. Accessed 19 Mar 2017 UR - https://www.tctmd.com/slide/everolimus-eluting-bioresorbable-vascular-scaffolds-patients-coronary-artery-disease-absorb ID - ref19 ER - TY - JOUR AU - Kraak, R. P. AU - Grundeken, M. J. AU - Hassell, M. E. AU - Elias, J. AU - Koch, K. T. AU - Henriques, J. P. PY - 2016 DA - 2016// TI - Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria JO - EuroIntervention. VL - 12 UR - https://doi.org/10.4244/EIJV12I5A95 DO - 10.4244/EIJV12I5A95 ID - Kraak2016 ER - TY - JOUR AU - Capodanno, D. AU - Gori, T. AU - Nef, H. AU - Latib, A. AU - Mehilli, J. AU - Lesiak, M. PY - 2015 DA - 2015// TI - Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry JO - EuroIntervention VL - 10 UR - https://doi.org/10.4244/EIJY14M07_11 DO - 10.4244/EIJY14M07_11 ID - Capodanno2015 ER - TY - JOUR AU - Stone, G. W. AU - Gao, R. AU - Kimura, T. AU - Kereiakes, D. J. AU - Ellis, S. G. AU - Onuma, Y. PY - 2016 DA - 2016// TI - 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)01039-9 DO - 10.1016/S0140-6736(15)01039-9 ID - Stone2016 ER - TY - JOUR AU - Cassese, S. AU - Byrne, R. A. AU - Ndrepepa, G. AU - Kufner, S. AU - Wiebe, J. AU - Repp, J. PY - 2016 DA - 2016// TI - Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)00979-4 DO - 10.1016/S0140-6736(15)00979-4 ID - Cassese2016 ER - TY - JOUR AU - Toyota, T. AU - Morimoto, T. AU - Shiomi, H. AU - Yoshikawa, Y. AU - Yaku, H. AU - Yamashita, Y. PY - 2017 DA - 2017// TI - Very Late Scaffold Thrombosis of Bioresorbable Vascular Scaffold: Systematic Review and a Meta-Analysis JO - JACC Cardiovasc Interv. VL - 10 UR - https://doi.org/10.1016/j.jcin.2016.10.027 DO - 10.1016/j.jcin.2016.10.027 ID - Toyota2017 ER - TY - STD TI - Nairooz R, Saad M, Sardar P, Aronow WS. Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis. Heart. 2017; doi:10.1136/heartjnl-2016-310886. ID - ref25 ER - TY - JOUR AU - Ha, F. J. AU - Nerlekar, N. AU - Cameron, J. D. AU - Bennett, M. R. AU - Meredith, I. T. AU - West, N. E. PY - 2017 DA - 2017// TI - Midterm Safety and Efficacy of ABSORB Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent: An Updated Meta-Analysis JO - JACC Cardiovasc Interv. VL - 10 UR - https://doi.org/10.1016/j.jcin.2016.11.054 DO - 10.1016/j.jcin.2016.11.054 ID - Ha2017 ER - TY - JOUR AU - Puricel, S. AU - Cuculi, F. AU - Weissner, M. AU - Schmermund, A. AU - Jamshidi, P. AU - Nyffenegger, T. PY - 2016 DA - 2016// TI - Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors JO - J Am Coll Cardiol VL - 67 UR - https://doi.org/10.1016/j.jacc.2015.12.019 DO - 10.1016/j.jacc.2015.12.019 ID - Puricel2016 ER - TY - JOUR AU - Tanaka, A. AU - Latib, A. AU - Jabbour, R. J. AU - Mitomo, S. AU - Regazzoli, D. AU - Leone, P. P. PY - 2017 DA - 2017// TI - Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution JO - JACC Cardiovasc Interv VL - 10 UR - https://doi.org/10.1016/j.jcin.2017.01.037 DO - 10.1016/j.jcin.2017.01.037 ID - Tanaka2017 ER - TY - JOUR AU - Sorrentino, S. AU - Rosa, S. AU - Ambrosio, G. AU - Mongiardo, A. AU - Spaccarotella, C. AU - Polimeni, A. PY - 2015 DA - 2015// TI - The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment JO - BMC Cardiovasc Disord VL - 15 UR - https://doi.org/10.1186/s12872-015-0163-5 DO - 10.1186/s12872-015-0163-5 ID - Sorrentino2015 ER - TY - JOUR AU - Imori, Y. AU - D'Ascenzo, F. AU - Gori, T. AU - Münzel, T. AU - Fabrizio, U. AU - Campo, G. PY - 2016 DA - 2016// TI - Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry JO - Cardiol J VL - 23 UR - https://doi.org/10.5603/CJ.a2016.0052 DO - 10.5603/CJ.a2016.0052 ID - Imori2016 ER - TY - JOUR AU - Biscaglia, S. AU - Ugo, F. AU - Ielasi, A. AU - Secco, G. G. AU - Durante, A. AU - D'Ascenzo, F. PY - 2016 DA - 2016// TI - Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) JO - Int J Cardiol VL - 208 UR - https://doi.org/10.1016/j.ijcard.2016.01.202 DO - 10.1016/j.ijcard.2016.01.202 ID - Biscaglia2016 ER - TY - JOUR AU - Biscaglia, S. AU - Secco, G. G. AU - Tumscitz, C. AU - Mario, C. AU - Campo, G. PY - 2015 DA - 2015// TI - Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system JO - Int J Cardiol VL - 182 UR - https://doi.org/10.1016/j.ijcard.2014.12.103 DO - 10.1016/j.ijcard.2014.12.103 ID - Biscaglia2015 ER - TY - JOUR AU - Biscaglia, S. AU - Campo, G. AU - Tebaldi, M. AU - Tumscitz, C. AU - Pavasini, R. AU - Fileti, L. PY - 2016 DA - 2016// TI - Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison JO - Int J Cardiovasc Imaging VL - 32 UR - https://doi.org/10.1007/s10554-015-0756-1 DO - 10.1007/s10554-015-0756-1 ID - Biscaglia2016 ER - TY - JOUR AU - Caiazzo, G. AU - Longo, G. AU - Giavarini, A. AU - Kilic, I. D. AU - Fabris, E. AU - Serdoz, R. PY - 2016 DA - 2016// TI - Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds JO - Int J Cardiol VL - 221 UR - https://doi.org/10.1016/j.ijcard.2016.07.033 DO - 10.1016/j.ijcard.2016.07.033 ID - Caiazzo2016 ER - TY - STD TI - Ielasi A, Varricchio A, Campo G, Leoncini M, Cortese B, Vicinelli P, et al. A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study. Catheter Cardiovasc Interv. 2016; doi:10.1002/ccd.26801. ID - ref35 ER -